Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 01/17/2020

Closing price: 62.98

Support price level:	N/A
Resistance price level:	$64.12
Relative strength index (14-day RSI)	25.9
Beta	0.93

GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
With a -8.3 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
GILD is one of this month's worst performers with a return of -4.1%, underperforming 90 percent of stocks in the S&P-100.
Down 3.2 percent, GILD is one of this week's biggest decliners.
Volatility is forecast to fall over the next month.
With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$61.62	$70.05	17.0%

200 day	50 day	20 day	10 day
$65.37	$65.59	$65.22	$64.62

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
26.5%	23.7%	23.7%	26.7%

There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than: